File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Implementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications

TitleImplementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications
Authors
Keywordsneostigmine: dose rationale
neuromuscular block: assessment
patient care
quality measures
Issue Date2018
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2044
Citation
Anaesthesia, 2018, v. 73 n. 9, p. 1067-1078 How to Cite?
AbstractInappropriate dosing of neostigmine for antagonism of neuromuscular blockade has been associated with postoperative pulmonary complications. We evaluated the effects of a quality improvement initiative tailored to optimise the use of neostigmine in antagonising neuromuscular blockade on postoperative pulmonary complications, costs and duration of hospital stay. The quality improvement initiative consisted of: a reduction in available neostigmine aliquot sizes; a cognitive aid; an educational component; and a financial incentive for the intra-operative documentation of train-of-four measurement before administration of neostigmine. We conducted a pre-specified analysis of data obtained in our quality improvement study. Additional analyses were conducted in a propensity-matched cohort. An interrupted time series design was used to discriminate between the intervention and a counterfactual scenario. We analysed 12,025 consecutive surgical cases performed in 2015. Postoperative pulmonary complications occurred in 220 (7.5%) of 2937 cases pre-intervention and 568 (6.3%) of 9088 cases post-intervention. Adjusted regression analyses showed significantly a lower risk of postoperative pulmonary complications (OR 0.73 (95%CI 0.61–0.88); p = 0.001), lower costs (incidence rate ratio 0.95 (95%CI 0.93–0.97); p < 0.001) and shorter duration of hospital stay (incidence rate ratio 0.91 (95%CI 0.87–0.94); p < 0.001) after implementation of the quality improvement initiative. Analyses in a propensity-matched sample (n = 2936 per group) and interrupted time series analysis (n = 27,202 cases) confirmed the findings. Our data show that a local, multifaceted quality improvement initiative can enhance the quality of intra-operative neuromuscular blocking agent utilisation, thereby reducing the incidence of postoperative pulmonary complications. © 2018 Association of Anaesthetists
Persistent Identifierhttp://hdl.handle.net/10722/272931
ISSN
2021 Impact Factor: 12.893
2020 SCImago Journal Rankings: 1.839
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRudolph, MI-
dc.contributor.authorChitilian, HV-
dc.contributor.authorNg, PY-
dc.contributor.authorTimm, FP-
dc.contributor.authorAgarwala, AV-
dc.contributor.authorDoney, AB-
dc.contributor.authorRamachandran, SK-
dc.contributor.authorHoule, TT-
dc.contributor.authorEikermann, M-
dc.date.accessioned2019-08-06T09:19:17Z-
dc.date.available2019-08-06T09:19:17Z-
dc.date.issued2018-
dc.identifier.citationAnaesthesia, 2018, v. 73 n. 9, p. 1067-1078-
dc.identifier.issn0003-2409-
dc.identifier.urihttp://hdl.handle.net/10722/272931-
dc.description.abstractInappropriate dosing of neostigmine for antagonism of neuromuscular blockade has been associated with postoperative pulmonary complications. We evaluated the effects of a quality improvement initiative tailored to optimise the use of neostigmine in antagonising neuromuscular blockade on postoperative pulmonary complications, costs and duration of hospital stay. The quality improvement initiative consisted of: a reduction in available neostigmine aliquot sizes; a cognitive aid; an educational component; and a financial incentive for the intra-operative documentation of train-of-four measurement before administration of neostigmine. We conducted a pre-specified analysis of data obtained in our quality improvement study. Additional analyses were conducted in a propensity-matched cohort. An interrupted time series design was used to discriminate between the intervention and a counterfactual scenario. We analysed 12,025 consecutive surgical cases performed in 2015. Postoperative pulmonary complications occurred in 220 (7.5%) of 2937 cases pre-intervention and 568 (6.3%) of 9088 cases post-intervention. Adjusted regression analyses showed significantly a lower risk of postoperative pulmonary complications (OR 0.73 (95%CI 0.61–0.88); p = 0.001), lower costs (incidence rate ratio 0.95 (95%CI 0.93–0.97); p < 0.001) and shorter duration of hospital stay (incidence rate ratio 0.91 (95%CI 0.87–0.94); p < 0.001) after implementation of the quality improvement initiative. Analyses in a propensity-matched sample (n = 2936 per group) and interrupted time series analysis (n = 27,202 cases) confirmed the findings. Our data show that a local, multifaceted quality improvement initiative can enhance the quality of intra-operative neuromuscular blocking agent utilisation, thereby reducing the incidence of postoperative pulmonary complications. © 2018 Association of Anaesthetists-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2044-
dc.relation.ispartofAnaesthesia-
dc.rightsThis is the peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article using the DOI]. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.-
dc.subjectneostigmine: dose rationale-
dc.subjectneuromuscular block: assessment-
dc.subjectpatient care-
dc.subjectquality measures-
dc.titleImplementation of a new strategy to improve the peri-operative management of neuromuscular blockade and its effects on postoperative pulmonary complications-
dc.typeArticle-
dc.identifier.emailNg, PY: pyeungng@hku.hk-
dc.identifier.authorityNg, PY=rp02517-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1111/anae.14326-
dc.identifier.pmid29974459-
dc.identifier.scopuseid_2-s2.0-85050407180-
dc.identifier.hkuros300516-
dc.identifier.volume73-
dc.identifier.issue9-
dc.identifier.spage1067-
dc.identifier.epage1078-
dc.identifier.isiWOS:000442206900004-
dc.publisher.placeUnited Kingdom-
dc.identifier.issnl0003-2409-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats